• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Absorption and protein binding of N-2-fluorenylacetamide and its metabolites in the bladder of rabbit.

作者信息

Hopp M L, Matsumoto M, Lee C, Oyasu R

出版信息

J Natl Cancer Inst. 1977 Feb;58(2):281-5. doi: 10.1093/jnci/58.2.281.

DOI:10.1093/jnci/58.2.281
PMID:833876
Abstract

To assess the reactivity of a bladder carcinogen, the absorption by the rabbit (male New Zealand White) bladder mucosa of N-2-acetylaminofluorene (AAF), N-hydroxy-2-acetyl-aminofluorene (N-OH-AAF), and the N-O-glucuronide of AAF (N-OGI-AAF), as well as binding to the protein and RNA of bladder mucosa, was measured in vivo and in vitro. Mucosal pieces incubated for 3 hours in medium containing a carcinogen demonstrated that the fluorene nucleus of both AAF and N-CH-AAF bound equally with cellular proteins, while N-OGI-AAF binding was lower. In the presence of an excess of beta-glucuronidase, however, N-OGI-AAF showed binding equivalent to its metabolic precursor. After a 3-hour instillation into the bladder lumen of radioactive carcinogens suspended in urine in vivo, transmural absorption of AAF and N-OH-AAF (90%) was substantial, while N-OGI-AAF was absorbed less (55%). The renal excretion during this period varied from 18 to 52% of the instilled radioactivity. There was little reactivity of these carcinogens with the mucosal RNA, both in vivo and in vitro. The metabolism of N-OH-AAF and N-OGI-AAF was such, both in vitro and in vivo, that the acetyl group was not included in the final protein-carcinogen complex in what appeared to be an enzyme reaction.

摘要

相似文献

1
Absorption and protein binding of N-2-fluorenylacetamide and its metabolites in the bladder of rabbit.
J Natl Cancer Inst. 1977 Feb;58(2):281-5. doi: 10.1093/jnci/58.2.281.
2
Suppressive role of indole on 2-acetylaminofluorene hepatotoxicity.吲哚对2-乙酰氨基芴肝毒性的抑制作用。
Cancer Res. 1976 Jan;36(1):234-9.
3
Production of urothelial tumors in the heterotopic bladder of rats by instillation of N-glucuronosyl or N-acetyl derivatives of N-hydroxy-2-aminofluorene.通过灌注 N-羟基-2-氨基芴的 N-葡糖醛酸基或 N-乙酰基衍生物在大鼠异位膀胱中产生尿路上皮肿瘤。
Cancer Res. 1987 Jul 1;47(13):3406-9.
4
Metabolism and activation of 2-acetylaminofluorene in isolated rat hepatocytes.2-乙酰氨基芴在分离的大鼠肝细胞中的代谢与活化
Cancer Res. 1979 Aug;39(8):3268-75.
5
Induction of DNA repair synthesis in human urothelial cells by the N-hydroxy metabolites of carcinogenic arylamines.致癌芳胺的N-羟基代谢产物对人尿道上皮细胞DNA修复合成的诱导作用。
J Natl Cancer Inst. 1984 Apr;72(4):847-52.
6
Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives.
Cancer Lett. 1977 May;2(6):319-22. doi: 10.1016/s0304-3835(77)80011-6.
7
Metabolism and DNA adduct formation of 2-acetylaminofluorene by bladder explants from human, dog, monkey, hamster and rat.人、狗、猴、仓鼠和大鼠膀胱外植体对2-乙酰氨基芴的代谢及DNA加合物形成
Carcinogenesis. 1984 Oct;5(10):1287-92. doi: 10.1093/carcin/5.10.1287.
8
Metabolism of 2-acetylaminofluorene in the Chinese hamster ovary cell mutation assay.2-乙酰氨基芴在中国仓鼠卵巢细胞突变试验中的代谢
Environ Mol Mutagen. 1988;11(2):167-81. doi: 10.1002/em.2850110203.
9
Metabolic activation of 2-aminofluorene, 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene to bacterial mutagens with mussel (Mytilus galloprovincialis) and carp (Cyprinus carpio) subcellular preparations.利用贻贝(加利福尼亚贻贝)和鲤鱼(鲤)亚细胞制剂将2-氨基芴、2-乙酰氨基芴和N-羟基-乙酰氨基芴代谢活化为细菌诱变剂。
Comp Biochem Physiol C Comp Pharmacol Toxicol. 1987;88(1):171-7. doi: 10.1016/0742-8413(87)90063-6.
10
Repair synthesis of DNA induced by the urinary N-hydroxy metabolites of carcinogenic arylamines in urothelial cells of susceptible species.致癌芳胺的尿N-羟基代谢物在易感物种膀胱上皮细胞中诱导的DNA修复合成。
Cancer Res. 1985 Jan;45(1):221-5.